Antibody-Drug Conjugates for HER2-Low Disease: 2023 KU Breast Cancer Year in Review Total Health | Oncology 2:06 1 year ago 92 Скачать Далее
HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review Conference Total Health | Oncology 25:20 1 year ago 2 144 Скачать Далее
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference Total Health | Oncology 27:03 1 year ago 11 476 Скачать Далее
Antibody Drug Conjugates Present and Future Applications in Breast Cancer Total Health | Oncology 25:46 4 months ago 376 Скачать Далее
Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate NEJM Group 11:25 4 months ago 50 Скачать Далее
Antibody Drug Conjugates in Metastatic Breast Cancer | Anthony Elias, MD | ESMO22 Colorado Total Health | Oncology 3:42 1 year ago 95 Скачать Далее
Hot Topics for Case Discussion in Breast Cancer: 2023 KU Breast Cancer Year in Review Total Health | Oncology 2:24 1 year ago 65 Скачать Далее
Antibody Drug Conjugates and Recent Applications in Breast Cancer Treatment Labroots 35:25 1 year ago 1 084 Скачать Далее
Preserving Fertility, and Genomic Assays in Breast Cancer: 2023 KU Breast Cancer Year in Review Total Health | Oncology 2:23 1 year ago 36 Скачать Далее
HER2-low breast cancer: the ESMO Expert Consensus Statements European Society for Medical Oncology (ESMO) 2:02 1 year ago 943 Скачать Далее
Treatment Options for HER2-Low Breast Cancer: All You Need to Know Yerbba – Breast Cancer 5:16 6 months ago 2 789 Скачать Далее
Novel antibody-drug conjugates (ADCs) technologies for management of mBC ecancer 10:21 1 year ago 90 Скачать Далее
TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal PeerView Oncology 51:40 1 year ago 907 Скачать Далее
Hot Topics in Advanced Breast Cancer: 2023 Best of Breast Conference Total Health | Oncology 6:29 1 year ago 400 Скачать Далее
HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery? | RTCL.TV Social RTCL TV 0:57 11 months ago 12 Скачать Далее
Historical Perspective on HR+/HER2- Breast Cancer: 2023 KU Breast Cancer Year in Review Total Health | Oncology 5:19 1 year ago 498 Скачать Далее
Emergence of antibody-drug conjugates in metastatic breast cancer: 2022 ESMO Florida Total Health | Oncology 2:40 1 year ago 48 Скачать Далее
Antibody-drug conjugates for the treatment of breast cancer VJOncology 1:23 2 years ago 308 Скачать Далее
The Science of HER2-low Breast Cancer and Implications for the Pathology Team ASCP 54:43 2 years ago 2 703 Скачать Далее